Compare Injective (INJ) vs Scallop (SCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Injective vs Scallop — how do they compare? Injective trades at Rp79,066 (market cap Rp7,99T, Rp683,48M 24h volume), while Scallop trades at Rp119.79 (market cap Rp24,21M, Rp19,2M 24h volume). The key difference: Injective is far larger — about 330028.9× Scallop's market cap, and Scallop's supply is capped (160,8M / 250M SCA (65%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 37 Days and Scallop for 14 Days on average.
| INJ | SCA | |
|---|---|---|
Market Cap | Rp7,99T | Rp24,21M |
Volume (24h) | Rp683,48M | Rp19,2M |
Circulating Supply | 100M INJ | 160,8M / 250M SCA (65%) |
Typical Hold Time | 37 Days | 14 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INJ is currently trading at Rp81,847 with a market cap of Rp8.18 trillion, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token faces immediate resistance at Rp82,576 with support at Rp81,456. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding patterns among investors.
Overall outlook remains cautious with technical indicators favoring bearish momentum. Key opportunities include potential bounce from support levels, while major risks involve continued selling pressure and crypto market volatility. Investors should monitor network adoption metrics and exchange liquidity closely.
Scallop (SCA) shows limited market activity with a modest market cap of Rp24.21M and 65% circulating supply. The token exhibits low trading volumes and minimal price discovery, trading near recent lows with weak momentum. Recent news suggests some institutional interest through ETF exposure, but on-chain activity remains subdued with a 14-day average hold time indicating cautious investor behavior.
Outlook remains cautious due to low liquidity and limited ecosystem development. Key opportunity lies in potential ETF-driven exposure, while major risks include extreme volatility from low market depth and regulatory uncertainty in the crypto space. Investors should monitor exchange listings and protocol updates for catalysts.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →About Scallop
Scallop is an advanced decentralized finance (DeFi) protocol built on the Sui blockchain. It offers a wide range of financial services, including lending, borrowing, automated market making (AMM), and asset management. Developed by Scallop Labs, which has a team of experts in DeFi, cybersecurity, and fintech, Scallop has attracted support from notable investors such as CMS Holdings, 6th Man Ventures, KuCoin Labs, and Mysten Labs. Additionally, it is the first DeFi project to receive an official grant from the Sui Foundation, highlighting its institutional-grade quality and strong security features.
Read more on SCA →
